Select Medical Holdings (SEM) Return on Equity ROE from the first quarter 2026 to first quarter 2025 and annually, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Select Medical Holdings Corp  (NYSE: SEM)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Select Medical Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Select Medical Holdings in the first quarter 2026?
Select Medical Holdings Corp achieved a return on average equity (ROE) of 10.05 % in its first quarter 2026, which is below Select Medical Holdings's average return on equity, which stands at 18.43%.

ROE fell compared to the fourth quarter 2025, despite the net income growth of 68.98% from the fourth quarter 2025.

Within the Healthcare Facilities industry 18 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from 1180 to 1429.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Equity Change 2.35 % 1.51 % -11.4 % 16.63 % -
Y / Y Net Income Change -14.66 % - -45.47 % -38.92 % -36.22 %
Net Income (TTM) in Millions 204 215 161 198 234
Return On Equity (TTM) 10.05 % 10.65 % 8.01 % 9.54 % 11.72 %
SEM's Total Ranking # 1429 # 1180 # 1310 # 1104 # 944
Equity (TTM) in Millions 2,085 2,017 2,011 1,991 2,037
Seq. Equity Change 3.37 % 0.28 % 1.03 % -2.27 % 2.52 %
Seq. Net Income Change 68.98 % -14.57 % -23.67 % -22.55 % -

Back to SEM Management Effectiveness >> SEM's 5 Years Annual ROE >> Compare SEM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 19
Sector # 141
Overall # 1429

Return On Equity Statistics
High Average Low
40.98 %
18.43 %
0.01 %
(Jun 30 2021)   (Sep 30 2017)





SEM Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 2,017 1,987 1,548 1,357 1,326
Y / Y Equity Change 1.51 % 28.38 % 14.09 % 2.31 % 5.82 %
Net Income in Millions 215 297 300 198 0
Y / Y Net Income Change -27.69 % -1.01 % 51.36 % - -
Return On Equity 10.64 % 14.93 % 19.37 % 14.6 % 0 %

Back to SEM Management Effectiveness >> SEM's 5 Years Annual ROE >> Compare SEM ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 10.64 %, due to deterioration of net income.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SEM's' Return on Equity at Yahoo Finance
SEM's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SEM's Competitors
Subscribers only: Roe for Select Medical Holdings's Suppliers
Subscribers only: Return On Equity for SEM's Customers




Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector ROE
Collegium Pharmaceutical Inc   26.74 %
Pacs Group Inc   26.46 %
Johnson and Johnson  26.26 %
Engene Therapeutics Inc   25.83 %
Encompass Health Corporation  25.56 %
Chemed Corporation  25.33 %
Resmed Inc   24.76 %
Iradimed Corporation  24.48 %
Lantheus Holdings Inc   24.33 %
Prestige Consumer Healthcare Inc   24.20 %
Vertex Pharmaceuticals Inc  23.93 %
Catalyst Pharmaceuticals Inc   23.65 %
Xoma Royalty Corporation  23.64 %
Soleno Therapeutics Inc  22.85 %
Electromed Inc   22.41 %
Iqvia Holdings Inc   22.15 %
Msa Safety Inc  22.03 %
Neurocrine Biosciences Inc   21.64 %
Insulet Corporation  21.38 %
Universal Health Services Inc   21.22 %
Teva Pharmaceutical Industries Limited  20.74 %
Exagen Inc   20.63 %
Sotera Health Company  20.57 %
Puma Biotechnology Inc   20.37 %
Pediatrix Medical Group Inc   20.09 %
Ge Healthcare Technologies Inc   19.37 %
Krystal Biotech Inc   19.25 %
United Therapeutics Corporation  19.24 %
Ani Pharmaceuticals Inc  18.02 %
Inspire Medical Systems inc   17.98 %

Date modified: 2026-09-26T06:56:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.